Valvular heart disease
Conditions
Interventions
Totally thoracoscopic approach under hypothermic ventricular fibrillation group:N/A
Median sternotomy group:N/A
Sponsors
Cardiovascular Surgery, First Medical Center, Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients had undergone previous cardiac surgery, including mitral valve surgery, aortic valve surgery, combined mitral and aortic valve surgery (double valve surgery, DVS), coronary artery bypass grafting (CABG), congenital heart disease surgery, and have developed new mitral valve disease requiring surgical treatment, such as bioprosthetic valve failure, mechanical valve dysfunction, infective endocarditis, mitral valve perivalvular leak, recurrent dysfunction after mitral valvuloplasty, and new onset of severe mitral valve regurgitation or stenosis.
Exclusion criteria
Exclusion criteria: 1. Patients who have undergone aortic surgery; 2. Patients requiring concurrent aortic surgery, aortic valve surgery or CABG; 3.Preoperatively hemodynamically unstable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality;Complication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Myocardial enzymes; | — |
Countries
China
Contacts
Public ContactJiang Shengli
Cardiovascular Surgery, First Medical Center, Chinese PLA General Hospital
Outcome results
None listed